Nayak, Sandeep M.

Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial

Raison, C. L., Sanacora, G., Woolley, J., Heinzerling, K., Dunlop, B. W., Brown, R. T., Kakar, R., Hassman, M., Trivedi, R. P., Robison, R., et al. (2023) · JAMA

Psychedelics and Drug StudiesTreatment of Major Depression

Cited by 545

Adverse Events in Studies of Classic Psychedelics: A Systematic Review and Meta-Analysis

Hinkle, J. T., Graziosi, M., Nayak, S. M., & Yaden, D. B. (2024) · JAMA psychiatry

Psychedelics and Drug StudiesSchizophrenia research and treatment

Cited by 156

The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorder

Levin, A. W., Lancelotta, R., Sepeda, N. D., Gukasyan, N., Nayak, S., Wagener, T. L., Barrett, F. S., Griffiths, R. R., & Davis, A. K. (2024) · PLoS ONE

Psychedelics and Drug StudiesPsychotherapy Techniques and Applications

Cited by 82

Psychedelics and psychotherapy

Nayak, S., & Johnson, M. W. (2021) · Pharmacopsychiatry

Psychedelics and Drug StudiesPsychotherapy Techniques and Applications

Cited by 71

Attenuation of psilocybin mushroom effects during and after SSRI/SNRI antidepressant use

Gukasyan, N., Griffiths, R. R., Yaden, D. B., Antoine, D. G., & Nayak, S. M. (2023) · Journal of Psychopharmacology

Psychedelics and Drug StudiesTreatment of Major Depression

Cited by 67

Psychedelics and psychotherapy: is the whole greater than the sum of its parts

Dworkin, R. H., McDermott, M. P., Nayak, S. M., & Strain, E. C. (2023) · Clinical Pharmacology & Therapeutics

Psychedelics and Drug StudiesPsychotherapy Techniques and Applications

Cited by 17